If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Trulicity ® (dulaglutide) injection
0.75 mg/0.5 mL, 1.5 mg/0.5 mL, 3mg/0.5mL, 4.5mg/0.5mLThis information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Dulaglutide is a clear, colorless solution available as a
0.75 mg/0.5 mL solution in a single-dose pen
1.5 mg/0.5 mL solution in a single-dose pen
3 mg/0.5 mL solution in a single-dose pen, and
4.5 mg/0.5 mL solution in a single-dose pen.1
There is no information on using 2 dulaglutide pens in situations when a patient’s dose has increased and the patient has remaining unused pens.
Lilly cannot make any recommendations on using 2 dulaglutide pens as this was not studied in clinical trials.
Enclosed Prescribing Information
TRULICITY® (dulaglutide) injection, for subcutaneous use, Lilly
1. Trulicity [package insert]. Indianapolis, IN: Eli Lilly and Company; 2020.
Glossary
Lilly = Eli Lilly and Company
Date of Last Review: September 10, 2020
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.
Available Mon - Fri, 9am - 7pm EST